Clinical Trials Browser

Completed × Multiple Myeloma × 30 days × Clear all

NCT03441958 2026-03-18

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

Phase 1/2 Completed

Multiple Myeloma

NCT01139476 2026-03-11

Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study

Other hematologic neoplasmPlasma cell

Leukemia, Multiple Myeloma

NCT03477539 2026-03-09

Daratumumab in Treating Transplant-Eligible Patients With Multiple Myeloma

Phase 2 Completed

49 enrolled 15 charts

Multiple Myeloma

NCT01758042 2026-03-06

BMT

Phase NA Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Immunoglobulin Light-chain Amyloidosis, Anemia, Aplastic, Anemia, Sickle Cell, Autoimmune Diseases, Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Thalassemia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Anemia, Diamond-Blackfan, Renal Insufficiency, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT03361306 2026-03-06

LCI-HEM-MYE-CRD-002: Carfilzomib-Revlimid-Dexamethasone-Elotuzumab in Relapsed/Refractory Multiple Myeloma

Phase 2 Completed

15 enrolled 26 charts

Multiple Myeloma, Recurrence

NCT03601078 2026-03-04

KarMMa-2

Phase 2 Completed

Multiple Myeloma, Recurrence

NCT04328662 2026-03-04

A Study of Ninlaro in Real World Clinical Practice in China

Multiple Myeloma, Neoplasms, Plasma Cell

NCT01919086 2026-03-02

Response Adapted Therapy With Bortezomib/Dexamethasone Followed by Addition of Lenalidomide in Non Responders as Initial Treatment for Patients With Multiple Myeloma

Phase 2 Completed

30 enrolled 13 charts

Multiple Myeloma

NCT06549634 2026-02-27

Biomarkers of AKI in Patients Receiving Daratumumab

GenitourinaryPlasma cell

Multiple Myeloma, Acute Kidney Injury

NCT00339963 2026-02-20

Genome Expression in Lymphoma, Leukemia and Multiple Myeloma

LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Plasma Cell

NCT02833610 2026-02-18

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

Phase 2 Completed

Multiple Myeloma

NCT05804032 2026-02-18

Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma

Phase 3 Completed

LymphoidPlasma cell

Immunoproliferative Disorders, Lymphoproliferative Disorders, Multiple Myeloma, Neoplasms, Paraproteinemias